August 4, 2010 — When Beaumont Hospital physicians recently held a heart screening for high school students, they found some surprising results. Of the 402 students screened, 34 students were advised to continue with sports and follow-up with their personal physicians and an additional five students were instructed to stop exercise until fully evaluated.

August 4, 2010 — In recent years, concerns have been raised both inside and outside of the U.S. Food and Drug Administration (FDA) about whether the current 510(k) program achieves its goals of making safe and effective devices available to the public while fostering innovation.

August 3, 2010 — Patient enrollment began in the EVOLVE clinical trial, which is designed to assess the safety and performance of the Boston Scientific Synergy Coronary Stent (previously referred to as the Evolution stent). It uses a bioabsorbable polymer and everolimus drug formulation to create a thin, uniform coating confined to the outer surface of the stent.

August 3, 2010 — Patients have the right to refuse or request the withdrawal of any unwanted medical treatment. In an article published in the online issue of Mayo Clinic Proceedings, investigators explore the legal and ethical permissibility of carrying out such a request specific to a ventricular assist device (VAD).

August 3, 2010 — St. Joseph’s Regional Medical Center (SJRMC) in Paterson, N.J., received the Chain of Survival Award from the Sudden Cardiac Arrest Association and accolades from New Jersey Gov. Chris Christie for its trendsetting work in using prehospital therapeutic cooling of cardiac arrest patients.

August 2, 2010 – Research by an international team of scientists, including a University of California (UC), Davis, nutritionist, provides new evidence that cocoa and other foods rich in a class of nutrients known as flavanols may improve the health of people with coronary artery disease, the nation's leading cause of death.

August 2, 2010 – The new Propaq MD Monitor/Defibrillator received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is specifically designed to meet the special needs of the military and air medical operations.

July 30, 2010 – A drug-eluting coronary bifurcation stent received CE mark this week for clinical use in Europe. The Axxess Biolimus A9-Eluting Coronary Bifurcation Stent System uses a bioabsorbable coating on a self-expanding stent made by Devax.

July 30, 2010 – An upgraded Holter monitoring system now features Windows 7 compatibility, improved Bluetooth functionality, advanced editing capabilities and multiple final report customization options. The upgrades to the Welch Allyn Holter System are designed to optimize clinician workflow for easier, faster and more efficient evaluations.

July 30, 2010 – The first prospective, randomized study evaluating the clinical feasibility of spinal cord stimulation (SCS), or neurostimulation, to improve clinical signs and symptoms of heart failure, began this week.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now